Deep Invasion Volume of the Primary Nasopharyngeal Carcinoma Predicts Treatment Outcome

References

1. 1.↵
   1. Ebrahimi A,
   2. Gil Z,
   3. Amit M, et al

   ; International Consortium for Outcome Research (ICOR) in Head and Neck Cancer. Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. JAMA Otolaryngol Head Neck Surg 2014;140:1138–48 doi:10.1001/jamaoto.2014.1548 pmid:25075712

   CrossRefPubMed
2. 2.↵
   1. Kuan EC,
   2. Clair JMS,
   3. Badran KW, et al

   . How does depth of invasion influence the decision to do a neck dissection in clinically N0 oral cavity cancer? Laryngoscope 2016;126:547–48 doi:10.1002/lary.25707 pmid:26666561

   CrossRefPubMed
3. 3.↵
   1. Aaboubout Y,
   2. van der Toom QM,
   3. de Ridder MAJ, et al

   . Is the depth of invasion a marker for elective neck dissection in early oral squamous cell carcinoma? Front Oncol 2021;11:628320 doi:10.3389/fonc.2021.628320 pmid:33777774

   CrossRefPubMed
4. 4.↵
   1. Amin MB,
   2. Edge SB,
   3. Greene FL, et al.

   , eds. AJCC Cancer Staging Manual. 8th ed. Springer-Verlag; 2017.
5. 5.↵
   1. Lydiatt WM,
   2. Patel SG,
   3. O’Sullivan B, et al

   . Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:122–37 doi:10.3322/caac.21389 pmid:28128848

   CrossRefPubMed
6. 6.↵
   1. Lee MK,
   2. Choi Y

   . Correlation between radiologic depth of invasion and pathologic depth of invasion in oral cavity squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 2023;136:106249 doi:10.1016/j.oraloncology.2022.106249 pmid:36417807

   CrossRefPubMed
7. 7.↵
   1. King AD,
   2. Zee B,
   3. Yuen EHY, et al

   . Nasopharyngeal cancers: which method should be used to measure these irregularly shaped tumors on cross-sectional imaging? Int J Radiat Oncol Biol Phys 2007;69:148–54 doi:10.1016/j.ijrobp.2007.02.032 pmid:17513065

   CrossRefPubMed
8. 8.↵
   1. Wong LM,
   2. Ai QYH,
   3. Poon DMC, et al

   . A convolutional neural network combined with positional and textural attention for the fully automatic delineation of primary nasopharyngeal carcinoma on non-contrast-enhanced MRI. Quant Imaging Med Surg 2021;11:3932–44 doi:10.21037/qims-21-196 pmid:34476179

   CrossRefPubMed
9. 9.↵
   1. Wong LM,
   2. Ai QYH,
   3. Mo FKF, et al

   . Convolutional neural network in nasopharyngeal carcinoma: how good is automatic delineation for primary tumor on a non-contrast-enhanced fat-suppressed T2-weighted MRI? Jpn J Radiology 2021;39:571–79 doi:10.1007/s11604-021-01092-x pmid:33544302

   CrossRefPubMed
10. 10.↵
    1. Ke L,
    2. Deng Y,
    3. Xia W, et al

    . Development of a self-constrained 3D DenseNet model in automatic detection and segmentation of nasopharyngeal carcinoma using magnetic resonance images. Oral Oncol 2020;110:104862 doi:10.1016/j.oraloncology.2020.104862 pmid:32615440

    CrossRefPubMed
11. 11.↵
    1. Wang Y,
    2. Chen H,
    3. Lin J, et al

    . Automatic detection and recognition of nasopharynx gross tumour volume (GTVnx) by deep learning for nasopharyngeal cancer radiotherapy through magnetic resonance imaging. Radiat Oncol 2023;18:76 doi:10.1186/s13014-023-02260-1 pmid:37158943

    CrossRefPubMed
12. 12.↵
    1. Ng WT,
    2. But B,
    3. Choi HCW, et al

    . Application of artificial intelligence for nasopharyngeal carcinoma management – a systematic review. Cancer Manag Res 2022;14:339–66 doi:10.2147/CMAR.S341583 pmid:35115832

    CrossRefPubMed
13. 13.↵
    1. King AD,
    2. Ahuja AT,
    3. Leung SF, et al

    . Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck 2000;22:275–81 doi:10.1002/(SICI)1097-0347(200005)22:3<275::AID-HED10>3.0.CO;2-N pmid:10748451

    CrossRefPubMedWeb of Science
14. 14.↵
    1. van den Brekel M,
    2. Stel H,
    3. Castelijns J, et al

    . Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990;177:379–84 doi:10.1148/radiology.177.2.2217772 pmid:2217772

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Brierley J,
    2. Gospodarowiez M,
    3. Wittekind C

    , eds. UICC TNM Classification of Malignant Tumours. 8th ed. Wiley-Blackwell Publishing Ltd; 2017:15
16. 16.↵
    1. Harrell FE,
    2. Lee KL,
    3. Mark DB

    . Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statist Med 1996;15:361–87 doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4

    CrossRef
17. 17.↵
    1. Uno H,
    2. Cai T,
    3. Pencina MJ, et al

    . On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med 2011;30:1105–17 doi:10.1002/sim.4154 pmid:21484848

    CrossRefPubMed
18. 18.↵
    1. Correa AF,
    2. Jegede O,
    3. Haas NB, et al

    . Predicting renal cancer recurrence: defining limitations of existing prognostic models with prospective trial-based validation. J Clin Oncol 2019;37:2062–71 doi:10.1200/JCO.19.00107 pmid:31216227

    CrossRefPubMed
19. 19.↵
    1. Moons KGM,
    2. Altman DG,
    3. Reitsma JB, et al

    . Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 2015;162:W1–73 doi:10.7326/M14-0698 pmid:25560730

    CrossRefPubMed
20. 20.↵
    1. Sandu K,
    2. Nisa L,
    3. Monnier P, et al

    . Clinicobiological progression and prognosis of oral squamous cell carcinoma in relation to the tumor invasive front: impact on prognosis. Acta Otolaryngol 2014;134:416–24 doi:10.3109/00016489.2013.849818 pmid:24628337

    CrossRefPubMed
21. 21.↵
    1. Jimenez L,
    2. Jayakar SK,
    3. Ow TJ, et al

    . Mechanisms of invasion in head and neck cancer. Arch Pathol Lab Med 2015;139:1334–48 doi:10.5858/arpa.2014-0498-RA pmid:26046491

    CrossRefPubMed
22. 22.↵
    1. O-Charoenrat P,
    2. Wongkajornsilp A,
    3. Rhys-Evans PH, et al

    . Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells. Int J Cancer 2004;111:174–83 doi:10.1002/ijc.20228 pmid:15197768

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Curry JM,
    2. Sprandio J,
    3. Cognetti D, et al

    . Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol 2014;41:217–34 doi:10.1053/j.seminoncol.2014.03.003 pmid:24787294

    CrossRefPubMed
24. 24.↵
    1. Feng AC,
    2. Wu MC,
    3. Tsai SYC, et al

    . Prevertebral muscle involvement in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;65:1026–35 doi:10.1016/j.ijrobp.2006.02.012 pmid:16682150

    CrossRefPubMed
25. 25.↵
    1. Ai QY,
    2. Hu CW,
    3. Bhatia KS, et al

    . Nasopharyngeal carcinoma: relationship between invasion of the prevertebral space and distant metastases. Eur Arch Otorhinolaryngol 2018;275:497–505 doi:10.1007/s00405-017-4825-z pmid:29188437

    CrossRefPubMed
26. 26.↵
    1. Cheng Y-K,
    2. Liu L-Z,
    3. Jiang N, et al

    . MRI-detected skull-base invasion: prognostic value and therapeutic implication in intensity-modulated radiotherapy treatment for nasopharyngeal carcinoma. Strahlenther Onkol 2014;190:905–11 doi:10.1007/s00066-014-0656-7 pmid:24763663

    CrossRefPubMed
27. 27.↵
    1. Chen L,
    2. Liu L,
    3. Mao Y, et al

    . Grading of MRI-detected skull-base invasion in nasopharyngeal carcinoma and its prognostic value. Head Neck 2011;33:1309–14 doi:10.1002/hed.21606 pmid:21837701

    CrossRefPubMed
28. 28.↵
    1. Chen F-P,
    2. Zhou G-Q,
    3. Qi Z-Y, et al

    . Prognostic value of cervical nodal tumor volume in nasopharyngeal carcinoma: analysis of 1230 patients with positive cervical nodal metastasis. PLoS One 2017;12:e0176995 doi:10.1371/journal.pone.0176995 pmid:28489930

    CrossRefPubMed
29. 29.↵
    1. Yuan H,
    2. Ai QY,
    3. Kwong DLW, et al

    . Cervical nodal volume for prognostication and risk stratification of patients with nasopharyngeal carcinoma, and implications on the TNM-staging system. Sci Rep 2017;7:10387 doi:10.1038/s41598-017-10423-w pmid:28871162

    CrossRefPubMed
30. 30.↵
    1. Ai Q-Y,
    2. King AD,
    3. Mo FKF, et al

    . Prediction of distant metastases from nasopharyngeal carcinoma: improved diagnostic performance of MRI using nodal volume in N1 and N2 stage disease. Oral Oncol 2017;69:74–79 doi:10.1016/j.oraloncology.2017.04.008 pmid:28559024

    CrossRefPubMed
31. 31.↵
    1. Miyoshi M,
    2. Ueno H,
    3. Hashiguchi Y, et al

    . Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg 2006;243:492–98 doi:10.1097/01.sla.0000205627.05769.08 pmid:16552200

    CrossRefPubMed
32. 32.↵
    1. Mukoyama N,
    2. Suzuki H,
    3. Hanai N, et al

    . Pathological tumor volume predicts survival outcomes in oral squamous cell carcinoma. Oncol Lett 2018;16:2471–77 doi:10.3892/ol.2018.8951 pmid:30013639

    CrossRefPubMed
33. 33.↵
    1. Chen C,
    2. Fei Z,
    3. Pan J, et al

    . Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Jpn J Clin Oncol 2011;41:537–42 doi:10.1093/jjco/hyq242 pmid:21242183

    CrossRefPubMed
34. 34.↵
    1. Lee C,
    2. Huang T,
    3. Lee M, et al

    . Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome. Radiat Oncol 2010;5:2–7 doi:10.1186/1748-717X-5-20

    CrossRefPubMed
35. 35.↵
    1. Tian Y-M,
    2. Xiao W-W,
    3. Bai L, et al

    . Impact of primary tumor volume and location on the prognosis of patients with locally recurrent nasopharyngeal carcinoma. Chin J Cancer 2015;34:247–53 doi:10.1186/s40880-015-0019-5 pmid:26063113

    CrossRefPubMed
36. 36.↵
    1. Qin L,
    2. Wu F,
    3. Lu H, et al

    . Tumor volume predicts survival rate of advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy. Otolaryngol Head Neck Surg 2016;155:598–605 doi:10.1177/0194599816644408 pmid:27071443

    CrossRefPubMed
37. 37.↵
    1. Lee AWM,
    2. Foo W,
    3. Law SCK, et al

    . Recurrent nasopharyngeal carcinoma: the puzzles of long latency. Int J Radiat Oncol Biol Phys 1999;44:149–56 doi:10.1016/s0360-3016(98)00524-0 pmid:10219808

    CrossRefPubMed
38. 38.↵
    1. Wong ECY,
    2. Hung JLC,
    3. Ng WT

    . Potential pitfalls in incorporating plasma Epstein-Barr virus DNA in the management of nasopharyngeal carcinoma. Head Neck 2020;42:446–55 doi:10.1002/hed.26018 pmid:31778007

    CrossRefPubMed